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SARS-CoV-2 belongs to the Coronaviridae family, 
and it was probably initially transmitted from wild 
animals to humans [1]. Since the outbreak of the 
COVID-19 epidemic in December 2019 in Wuhan, 
China, the whole world is fighting an ever-grow-
ing pandemic, which becomes a global threat. The 
number of confirmed cases constantly increases 
and amounts to almost 1 500 000, however, the 
number of infected people is increasing contin-
uously, although at present the number of daily 
COVID-19 deaths is decreasing in some European 
countries, including Spain and Italy. With droplet 
transmission, virus released in the respiratory secre-
tions when a person with infection coughs, sneez-
es or talks can infect another person if it makes 
direct contact with the mucous membranes [2]. 
The available research results show that the virus is 
a single-stranded RNA virus that belongs to the ge-
nus Beta-coronavirus, and in its sequence uses the 
receptor for convertase-2-angiotensin (ACE-2). This 
enzyme serves as the entry point into cells for SARS-
CoV-2 and may result in increased expression of 
proteins that cause damage to the lung alveolar sys-
tem [3]. Based on analyzed cases, COVID-19 causes 
many symptoms including fever, dry cough, but 
more serious problem is bronchitis, pneumonia and 
ARDS. It was observed that younger patient can 
show severe disease symptoms, which is caused by 
non-educated immune system [4]. Elderly people 
and people with pre-existing medical conditions 
like hypertension, diabetes or cancer are more likely 
to become infected with a higher risk of severe 
COVID-19 and virus-related death [5]. The World 
Health Organization (WHO) published guidelines on 
how to avoid SARS-CoV-2 infection. Observing the 
rules of hygiene, reducing contact with other peo-
ple the spread of the virus can be reduced. This is 
especially important because there are currently no 
medications or vaccines that can help avoid infec-
tion or cure its effects. The biggest problem is that 
we do not have enough knowledge about SARS-
CoV-2. It is a new pathogen that is highly trans-
mittable and should be seen as a real threat. We 
should not refer to other diseases caused by other 
viruses but build knowledge based on constantly 
collected data. The most common clinical features 
at the onset of illness were: fever (87.9%), dry 
cough (67.7%), fatigue (38.1%), sputum produc-
tion (33.4%), shortness of breath (18.6%) and sore 
throat (13.9%). Signs and symptoms are developed 
about 5–6 days after infection [6]. This is a huge 
threat to healthcare professionals. This means that 
infected patients with non-specific symptoms can 
easily infect during physical examination. Healthcare 
workers are in constant contact with them and after 
infection, they spread the virus to other co-workers 
before they develop symptoms. This is evidenced 
by the fact that 3.5% of infected people are health-
care workers [7]. In a case series of 138 patients 
treated in a Wuhan hospital, 40 patients (29% of 
cases) were HCWs (31 (77.5%) worked on general 
wards, 7 (17.5%) in the emergency department, 
and 2 (5%) in the intensive care unit)2. What is 
worst, they can infect other sick patients in hospital 
who are the most vulnerable group that had a case 
fatality rate of 10.5% for cardiovascular disease, 
7.3% for diabetes, 6.3% for chronic respiratory 
disease, 6.0% for hypertension and 5.6% for cancer 
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[3, 8]. This means that we can expect an increase in 
the mortality of patients whose lives could be saved 
before the pandemic. Acute respiratory distress syn-
drome (ARDS) is a major complication. Common 
complications of COVID-19-related ARDS include 
acute kidney injury (AKI), elevated liver enzymes, 
and cardiac injury including cardiomyopathy, peri-
carditis, pericardial effusion, arrhythmia, and sud-
den cardiac death [8]. Protection against this virus 
as well as against any other infectious disease con-
sists primarily in preventive measures. Maintaining 
hygiene and maintaining adequate distance from 
the patient. This includes maintaining a minimum 
distance of 1.5 m (however, this distance should 
probably be increased), frequent hand washing 
minimum 30 s, disinfecting hands, not touching 
the face with hands, hygiene of the upper respirato-
ry tract, wearing a mask with FFP2 filter, using PPE, 
disinfecting things and rooms [9].
In many countries, healthcare workers are par-
ticularly exposed to SARS-CoV-2 and account for 
a significant proportion of the infected population. 
However, the experience of the Chinese and Italian 
hospitals shows that infections of healthcare work-
ers can be significantly reduced by strictly following 
the recommendations for the use of personal pro-
tective equipment and proper workplace manage-
ment, including the limitation of working time to 
a maximum of 6 hours. Of course, testing for SARS-
CoV-2 and the availability of personal protective 
equipment and disinfectants are essential.
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